Other domain extensions for you to consider.

.bms Domain Information

Country flagLogo for .bms Domain

Biopharmaceutical research and therapies sit behind .bms, a three-letter closed extension from ICANN's 2012 New gTLD Program. Pharmaceutical applicants faced a combination of pressures that made an owned namespace attractive: counterfeit medicine sales operate almost entirely through domains, and prescription product information is subject to jurisdiction-specific regulation that requires tight control over where content is published and who can publish it.

Domains under .bms support therapy-area and clinical content, healthcare professional resources, country sites, and corporate destinations. No public registration route exists and the extension has no aftermarket. The short string adds a defensive dimension, since three-letter abbreviations attract typed traffic and would be exploited if left available.

Registry Contact and Nameservers

  • Sponsoring Organization
    Bristol-Myers Squibb Company
    345 Park Avenue
    New York NY 10154
    United States of America (the)
  • Administrative Contact
    Sr. Advisor, Asset Management
    Bristol-Myers Squibb Company
    345 Park Avenue
    New York NY 10154
    United States of America (the)
    Email: [email protected]
    Voice: +1 609 818 3151
    Fax: +1 609-818-4219
  • Technical Contact
    Howard Eland, Senior Director, DNS Infrastructure Group
    Identity Digital Inc.
    10500 NE 8th Street, Suite 750
    Bellevue WA 98004
    United States of America (the)
    Email: [email protected]
    Voice: +1.425.298.2200
    Fax: +1.425.671.0020
  • Nameservers
    Host NameIP Address(es)
    a0.nic.bms 65.22.112.45
    2a01:8840:6e:0:0:0:0:45
    a2.nic.bms 65.22.115.45
    2a01:8840:71:0:0:0:0:45
    b0.nic.bms 65.22.113.45
    2a01:8840:6f:0:0:0:0:45
    c0.nic.bms 65.22.114.45
    2a01:8840:70:0:0:0:0:45